L Agaoglu
Overview
Explore the profile of L Agaoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarper N, Ozbek U, Agaoglu L, Ozgen U, Kandilci A, Sirma S, et al.
Turk J Haematol
. 2016 Jun;
17(4):197-206.
PMID: 27263637
BCR/ABL expression, which is the molecular equivalent of the Philadelphia chromosome, is an independent poor risk factor in acute lymphoblastic leukemia (ALL). We used a two-step (nested) reverse transcriptase polimerase...
2.
Ozgen U, Anak S, Ozbek U, Sarper N, Eryilmaz E, Agaoglu L, et al.
Turk J Haematol
. 2016 Jun;
17(4):183-8.
PMID: 27263635
Wilms tumor 1 (WT1) gene is a tumor supressor gene, expressed in malignant and normal hematopoietic progenitor cells. Prognostic significance of this gene in childhood acute lymphoid leukemia (ALL) is...
3.
Saribeyoglu E, Anak S, Agaoglu L, Boral O, Unuvar A, Devecioglu O
Pediatr Hematol Oncol
. 2004 Jun;
21(3):267-72.
PMID: 15202166
Since the first description of infection-associated hemophagocytosis (IAHS), the list of precipitating infectious agents causing hemophagocytic syndrome has grown. A lymphohistiocytic proliferation with hemophagocytosis may develop as a result of...
4.
Agaoglu L, Devecioglu O, Anak S, Karakas Z, Yalman N, Biner B, et al.
J Chemother
. 2001 Jul;
13(3):281-7.
PMID: 11450887
Infection remains the major cause of morbidity and mortality in immunocompromised children with malignancy. In addition, the economic impact of antibiotic treatment should always be evaluated, especially in developing countries....
5.
Yalman N, Sarper N, Devecioglu O, Anak S, Eryilmaz E, Can M, et al.
Turk J Pediatr
. 2000 Dec;
42(3):198-204.
PMID: 11105617
The prognosis of relapsed acute leukemia or chronic leukemia in acute blast crisis is poor and new chemotherapeutic regimens could be useful for these patients. Six relapsed acute lymphoblastic leukemia...
6.
Sarper N, Ozbek U, Agaoglu L, Ozgen U, Eryilmaz E, Yalman N, et al.
Pediatr Hematol Oncol
. 2000 Oct;
17(7):577-83.
PMID: 11033733
To assess the clinical significance of AML1/ETO gene detected by nested reverse transcriptase polymerase chain reaction, the outcome of 7 patients with acute myeloblastic leukemia between 3 and 14 years...
7.
Ozgen U, Anak S, Ozbek U, Sarper N, Eryilmaz E, Agaoglu L, et al.
Acta Haematol
. 2000 Oct;
103(4):229-30.
PMID: 11014901
No abstract available.
8.
Karakas Z, Agaoglu L, Biner B, Devecioglu O, Anak S, Yalman N, et al.
Acta Med Okayama
. 2000 Sep;
54(4):173-7.
PMID: 10985177
Fifty-one children (median age: 4.5 years; 4 months-16 years) diagnosed with rhabdomyosarcoma were treated in our center between 1980-1999. The primary sites were head and neck in 31.4%, the genito-urinary...
9.
Devecioglu O, Biner B, Karabocuoglu M, Unuvar A, Agaoglu L
Med Pediatr Oncol
. 2000 Feb;
34(2):151-2.
PMID: 10657881
No abstract available.
10.
Karakas Z, Agaoglu L, Erdem S, Anak S, Hacibektasoglu A, Gedikoglu G
Adv Exp Med Biol
. 1999 Sep;
457:453-9.
PMID: 10500822
No abstract available.